ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 957,57
0,54%
Dow Jones
38 675,68
1,18%
DAX
18 001,60
0,54%
Brent Oil
82,765
0,00%
Bitcoin
62 733,36
-0,25%
Registration Strip Icon for alerts Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. L'Europe
  5. EU
  6. Galapagos (GLPG)

  7. Galapagos (GLPG) Actualités

GLPG

Galapagos (GLPG)

Galapagos
De:
Trier par:
 Showing the most relevant articles for your search:EU:GLPG
DateHeureSourceTitreSymboleSociété
02/05/202422h01GlobeNewswire Inc.Galapagos reports first quarter 2024 financial results  EU:GLPGGalapagos
30/04/202422h01GlobeNewswire Inc.Galapagos’ shareholders adopt all resolutions proposed by the Board of Directors at the Annual and Extraordinary Shareholders Meetings 2024EU:GLPGGalapagos
04/04/202422h01GlobeNewswire Inc.Galapagos showcases innovative approach in hematological cancer care with clinical and translational data presentations at EBMT congress 2024EU:GLPGGalapagos
28/03/202421h01GlobeNewswire Inc.Galapagos publishes 2023 annual report and announces Annual and Extraordinary Shareholders’ MeetingsEU:GLPGGalapagos
26/03/202421h01GlobeNewswire Inc.Galapagos appoints Andrew Dickinson as Non-Executive Non-Independent Director to its BoardEU:GLPGGalapagos
22/02/202422h01GlobeNewswire Inc.Galapagos announces full year 2023 results and outlook for 2024EU:GLPGGalapagos
15/02/202422h01GlobeNewswire Inc.Galapagos presents at EBMT-EHA annual meeting 2024EU:GLPGGalapagos
31/01/202422h01GlobeNewswire Inc.Galapagos completes transaction to transfer Jyseleca® business to AlfasigmaEU:GLPGGalapagos
04/01/202422h44Dow Jones NewsGalapagos, Thermo Fisher to Collaborate on Expanding Manufacturing of Cancer DrugEU:GLPGGalapagos
04/01/202422h01GlobeNewswire Inc.Galapagos enters into strategic collaboration agreement with Thermo Fisher Scientific to further expand its decentralized CAR-T manufacturing network in the U.S.EU:GLPGGalapagos
03/01/202422h01GlobeNewswire Inc.Galapagos establishes strategic collaboration with BridGene Biosciences to expand small molecule drug discovery in oncologyEU:GLPGGalapagos
02/01/202407h00GlobeNewswire Inc.Galapagos signs agreement to transfer Jyseleca® business to AlfasigmaEU:GLPGGalapagos
19/12/202322h01GlobeNewswire Inc.Galapagos announces start of PAPILIO-1 Phase 1/2 multiple myeloma study of point-of-care manufactured BCMA CAR-T candidate, GLPG5301EU:GLPGGalapagos
09/12/202318h00GlobeNewswire Inc.Galapagos presents new encouraging data at ASH 2023 from ongoing CD19 CAR-T studies with GLPG5201 and GLPG5101EU:GLPGGalapagos
07/12/202322h01GlobeNewswire Inc.Galapagos to Host KOL Event on December 10, 2023, at 11:00 AM PST to discuss new data presented at ASH 2023EU:GLPGGalapagos
02/11/202321h01GlobeNewswire Inc.Galapagos reports third quarter 2023 results and releases new encouraging data from CAR-T studies for presentation at ASH 2023EU:GLPGGalapagos
30/10/202321h01GlobeNewswire Inc.Galapagos concludes strategic evaluation and signs letter of intent to transfer Jyseleca® business to AlfasigmaEU:GLPGGalapagos
19/09/202322h01GlobeNewswire Inc.Galapagos appoints Simon Sturge to its Board of DirectorsEU:GLPGGalapagos
28/08/202322h01GlobeNewswire Inc.Galapagos announces start of Phase 2 study with selective TYK2 inhibitor, GLPG3667, in patients with active systemic lupus erythematosus  EU:GLPGGalapagos
03/08/202322h01GlobeNewswire Inc.Galapagos announces first half-year 2023 financial resultsEU:GLPGGalapagos
15/06/202322h01GlobeNewswire Inc.Galapagos appoints Thad Huston as Chief Financial Officer and Chief Operating OfficerEU:GLPGGalapagos
12/06/202322h01GlobeNewswire Inc.Galapagos appoints Dr. Susanne Schaffert as non-executive independent Director to its BoardEU:GLPGGalapagos
05/06/202322h01GlobeNewswire Inc.Galapagos to showcase CAR-T point-of-care manufacturing and initial Phase 1/2 CLL data with CD19 CAR-T candidate, GLPG5201, at the EHA 2023 congressEU:GLPGGalapagos
23/05/202322h01GlobeNewswire Inc.Galapagos announces start of Phase 2 study with selective TYK2 inhibitor, GLPG3667, in patients with dermatomyositisEU:GLPGGalapagos
22/05/202322h01GlobeNewswire Inc.Galapagos demonstrates commitment to immunology with new data in rheumatoid arthritis at EULAR 2023EU:GLPGGalapagos
05/05/202322h01GlobeNewswire Inc.Galapagos creates new subscription right plansEU:GLPGGalapagos
04/05/202322h01GlobeNewswire Inc.Galapagos announces first quarter 2023 financial resultsEU:GLPGGalapagos
02/05/202322h01GlobeNewswire Inc.Galapagos announces departure of Bart Filius, Chief Operating Officer and Chief Financial OfficerEU:GLPGGalapagos
26/04/202322h01GlobeNewswire Inc.Galapagos initiates Phase 3 program with filgotinib in patients with active axial spondyloarthritisEU:GLPGGalapagos
25/04/202322h01GlobeNewswire Inc.Galapagos’ shareholders approve all resolutions proposed by the Board of Directors at the annual shareholders’ meetingEU:GLPGGalapagos
 Showing the most relevant articles for your search:EU:GLPG

Dernières Valeurs Consultées

SPI
SP500
S&P 500
EU
CAP
Capgemini
NASDAQ
GOOGL
Alphabet
EU
GLE
Societe Generale
EU
EN
Bouygues
EU
ACA
Credit Agricole
NYSE
MCD
McDonalds
EU
DG
Vinci
NASDAQ
AAPL
Apple
NYSE
MRK
Merck
NYSE
JPM
JP Morgan Chase
COIN
ETHUSD
Ethereum
EU
CS
Axa
EU
MC
Lvmh Moet Hennessy Louis...
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés